Do IL-3/GM-CSF effect on the myofibroblastic differentiation of human adipose derived stromal cells?

Jae Sun Lee, Son Seung Tae, Deok Yeol Kim, Seung-Kyu Han, Woo-Kyung Kim, Eun-Sang Dhong

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background Capsular contracture is an incurable complication after silicone-based implant surgery. Myofibroblast is the predominant cell in the contracted capsule. We hypothesized that human adipose derive stromal cells (hASCs) together with fibroblast may show a similar phenotypic characteristics of myofibroblast after the treatment of inflammatory cytokines in vitro. Materials and methods Interleukin 3 (IL-3) and granulocyte macrophage colony stimulating factor (GM-CSF) were treated in the culture of hASCs and HDFs. Lyn peptide inhibitor was applied as an inhibitor. The changes of cell surface markers (CD105, CD73, CD34, CD45, CD31, CD325 and CD146) were assessed. The expression of various cytokines related to wound contraction were tested such as TGF-β, α-SMA, HGF, FGF, ENT-1, and TSP-1. Myo-D, α-SMA, and glial fibrillary acidic protein (GFAP) were evaluated by blotting and immunocytochemical staining. The collagen-gel contraction assay was performed for the functional contraction of myofibroblastic phenotype. Results The expression of α-SMA, Myo-D and GFAP after the treatment of IL-3/GM-CSF showed similar results in hASCs and HDFs. Enhanced expression of TGF- β was observed in HDFs and the increase of ENT-1 and TSP-1 was significant in hASCs. Collagen-gel with HDFs contracted significantly within 24 h after the treatment of IL-3/GM-CSF, and the contraction was inhibited by Lyn peptide inhibitor. But in hASCs, the gel-contraction was not significant. Conclusion IL-3/ GM-CSF effected on the myofibroblastic differentiation of hASCs as well as it did on HDFs. But hASCs did not show the phenotypic gel-contraction within 24 h.

Original languageEnglish
Pages (from-to)67-82
Number of pages16
JournalExperimental Cell Research
Volume355
Issue number2
DOIs
Publication statusPublished - 2017 Jun 15

Fingerprint

Interleukin-3
Granulocyte-Macrophage Colony-Stimulating Factor
Stromal Cells
Gels
Thrombospondin 1
Myofibroblasts
Glial Fibrillary Acidic Protein
Collagen
Cytokines
Fibroblast Growth Factor 1
Peptides
Contracture
Silicones
Capsules
Fibroblasts
Staining and Labeling
Phenotype
Wounds and Injuries

Keywords

  • Granulocyte macrophage-colony stimulating factor
  • Interleukin-3
  • Myofibroblast
  • Stem cell

ASJC Scopus subject areas

  • Cell Biology

Cite this

Do IL-3/GM-CSF effect on the myofibroblastic differentiation of human adipose derived stromal cells? / Lee, Jae Sun; Tae, Son Seung; Kim, Deok Yeol; Han, Seung-Kyu; Kim, Woo-Kyung; Dhong, Eun-Sang.

In: Experimental Cell Research, Vol. 355, No. 2, 15.06.2017, p. 67-82.

Research output: Contribution to journalArticle

Lee, Jae Sun ; Tae, Son Seung ; Kim, Deok Yeol ; Han, Seung-Kyu ; Kim, Woo-Kyung ; Dhong, Eun-Sang. / Do IL-3/GM-CSF effect on the myofibroblastic differentiation of human adipose derived stromal cells?. In: Experimental Cell Research. 2017 ; Vol. 355, No. 2. pp. 67-82.
@article{3acd1e08a2d34c59a90bdb37223b1cf1,
title = "Do IL-3/GM-CSF effect on the myofibroblastic differentiation of human adipose derived stromal cells?",
abstract = "Background Capsular contracture is an incurable complication after silicone-based implant surgery. Myofibroblast is the predominant cell in the contracted capsule. We hypothesized that human adipose derive stromal cells (hASCs) together with fibroblast may show a similar phenotypic characteristics of myofibroblast after the treatment of inflammatory cytokines in vitro. Materials and methods Interleukin 3 (IL-3) and granulocyte macrophage colony stimulating factor (GM-CSF) were treated in the culture of hASCs and HDFs. Lyn peptide inhibitor was applied as an inhibitor. The changes of cell surface markers (CD105, CD73, CD34, CD45, CD31, CD325 and CD146) were assessed. The expression of various cytokines related to wound contraction were tested such as TGF-β, α-SMA, HGF, FGF, ENT-1, and TSP-1. Myo-D, α-SMA, and glial fibrillary acidic protein (GFAP) were evaluated by blotting and immunocytochemical staining. The collagen-gel contraction assay was performed for the functional contraction of myofibroblastic phenotype. Results The expression of α-SMA, Myo-D and GFAP after the treatment of IL-3/GM-CSF showed similar results in hASCs and HDFs. Enhanced expression of TGF- β was observed in HDFs and the increase of ENT-1 and TSP-1 was significant in hASCs. Collagen-gel with HDFs contracted significantly within 24 h after the treatment of IL-3/GM-CSF, and the contraction was inhibited by Lyn peptide inhibitor. But in hASCs, the gel-contraction was not significant. Conclusion IL-3/ GM-CSF effected on the myofibroblastic differentiation of hASCs as well as it did on HDFs. But hASCs did not show the phenotypic gel-contraction within 24 h.",
keywords = "Granulocyte macrophage-colony stimulating factor, Interleukin-3, Myofibroblast, Stem cell",
author = "Lee, {Jae Sun} and Tae, {Son Seung} and Kim, {Deok Yeol} and Seung-Kyu Han and Woo-Kyung Kim and Eun-Sang Dhong",
year = "2017",
month = "6",
day = "15",
doi = "10.1016/j.yexcr.2017.03.056",
language = "English",
volume = "355",
pages = "67--82",
journal = "Experimental Cell Research",
issn = "0014-4827",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Do IL-3/GM-CSF effect on the myofibroblastic differentiation of human adipose derived stromal cells?

AU - Lee, Jae Sun

AU - Tae, Son Seung

AU - Kim, Deok Yeol

AU - Han, Seung-Kyu

AU - Kim, Woo-Kyung

AU - Dhong, Eun-Sang

PY - 2017/6/15

Y1 - 2017/6/15

N2 - Background Capsular contracture is an incurable complication after silicone-based implant surgery. Myofibroblast is the predominant cell in the contracted capsule. We hypothesized that human adipose derive stromal cells (hASCs) together with fibroblast may show a similar phenotypic characteristics of myofibroblast after the treatment of inflammatory cytokines in vitro. Materials and methods Interleukin 3 (IL-3) and granulocyte macrophage colony stimulating factor (GM-CSF) were treated in the culture of hASCs and HDFs. Lyn peptide inhibitor was applied as an inhibitor. The changes of cell surface markers (CD105, CD73, CD34, CD45, CD31, CD325 and CD146) were assessed. The expression of various cytokines related to wound contraction were tested such as TGF-β, α-SMA, HGF, FGF, ENT-1, and TSP-1. Myo-D, α-SMA, and glial fibrillary acidic protein (GFAP) were evaluated by blotting and immunocytochemical staining. The collagen-gel contraction assay was performed for the functional contraction of myofibroblastic phenotype. Results The expression of α-SMA, Myo-D and GFAP after the treatment of IL-3/GM-CSF showed similar results in hASCs and HDFs. Enhanced expression of TGF- β was observed in HDFs and the increase of ENT-1 and TSP-1 was significant in hASCs. Collagen-gel with HDFs contracted significantly within 24 h after the treatment of IL-3/GM-CSF, and the contraction was inhibited by Lyn peptide inhibitor. But in hASCs, the gel-contraction was not significant. Conclusion IL-3/ GM-CSF effected on the myofibroblastic differentiation of hASCs as well as it did on HDFs. But hASCs did not show the phenotypic gel-contraction within 24 h.

AB - Background Capsular contracture is an incurable complication after silicone-based implant surgery. Myofibroblast is the predominant cell in the contracted capsule. We hypothesized that human adipose derive stromal cells (hASCs) together with fibroblast may show a similar phenotypic characteristics of myofibroblast after the treatment of inflammatory cytokines in vitro. Materials and methods Interleukin 3 (IL-3) and granulocyte macrophage colony stimulating factor (GM-CSF) were treated in the culture of hASCs and HDFs. Lyn peptide inhibitor was applied as an inhibitor. The changes of cell surface markers (CD105, CD73, CD34, CD45, CD31, CD325 and CD146) were assessed. The expression of various cytokines related to wound contraction were tested such as TGF-β, α-SMA, HGF, FGF, ENT-1, and TSP-1. Myo-D, α-SMA, and glial fibrillary acidic protein (GFAP) were evaluated by blotting and immunocytochemical staining. The collagen-gel contraction assay was performed for the functional contraction of myofibroblastic phenotype. Results The expression of α-SMA, Myo-D and GFAP after the treatment of IL-3/GM-CSF showed similar results in hASCs and HDFs. Enhanced expression of TGF- β was observed in HDFs and the increase of ENT-1 and TSP-1 was significant in hASCs. Collagen-gel with HDFs contracted significantly within 24 h after the treatment of IL-3/GM-CSF, and the contraction was inhibited by Lyn peptide inhibitor. But in hASCs, the gel-contraction was not significant. Conclusion IL-3/ GM-CSF effected on the myofibroblastic differentiation of hASCs as well as it did on HDFs. But hASCs did not show the phenotypic gel-contraction within 24 h.

KW - Granulocyte macrophage-colony stimulating factor

KW - Interleukin-3

KW - Myofibroblast

KW - Stem cell

UR - http://www.scopus.com/inward/record.url?scp=85017398412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017398412&partnerID=8YFLogxK

U2 - 10.1016/j.yexcr.2017.03.056

DO - 10.1016/j.yexcr.2017.03.056

M3 - Article

VL - 355

SP - 67

EP - 82

JO - Experimental Cell Research

JF - Experimental Cell Research

SN - 0014-4827

IS - 2

ER -